ResearcherNational Hospital Organization Kyushu Cancer CenterNo recent work listed

Soichi Takiguchi

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5015130281. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper

Papers 2

Crizotinib, a MET inhibitor, prevents peritoneal dissemination in pancreatic cancer. Co-author DOI 10.3892/ijo.2017.3992 ↗
A humanized anti-IGF-1R monoclonal antibody (R1507) and/or metformin enhance gemcitabine-induced apoptosis in pancreatic cancer cells. Co-author DOI 10.3892/or.2011.1597 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Haruo Iguchi · 1 shared paper, 2017 · strength 0.08
- Paper Crizotinib, a MET inhibitor, prevents peritoneal dissemination in pancreatic cancer. DOI 10.3892/ijo.2017.3992 ↗
Masayuki Furukawa · 1 shared paper, 2017 · strength 0.08
- Paper Crizotinib, a MET inhibitor, prevents peritoneal dissemination in pancreatic cancer. DOI 10.3892/ijo.2017.3992 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.